deficit de hierro

¿Es usted
profesional sanitario?

No

Está usted accediendo a la página web “Déficit de Hierro”, dirigida a difundir información médica y promover la formación sobre los estados carenciales de hierro y la anemia ferropénica.

La información contenida en esta página está destinada exclusivamente a profesionales sanitarios con capacidad para prescribir o dispensar medicamentos, por lo que se requiere una formación especializada para su correcta interpretación. Si Vd. no es profesional sanitario cualificado, Zambon no se hace responsable de los perjuicios que pueda sufrir por las decisiones basadas en el contenido de esta página o de cualquiera de sus enlaces.

+

Selección bibliográfica de artículos


Semestralmente se realiza una actualización de la revisión bibliográfica según los criterios establecidos.

La selección actual de artículos corresponde a material publicado desde enero de 2013 hasta febrero de 2017.

Los usuarios pueden solicitar a la Secretaría Científica el envío vía e-mail de aquellos artículos que sean de su interés.


Hematología

  • Hepcidin in the diagnosis of iron disorders.
    Girelli D, Nemeth E, Swinkels DW.
    Blood. 2016 Jun 9;127(23):2809-13. doi: 10.1182/blood-2015-12-639112. Epub 2016 Apr 4.

  • A Rare Cause of Unexplained Refractory Iron Deficiency Anemia: Unicentric Plasma-Cell Type Castleman's Disease.
    Kalayoğlu Beşışık S, Yönal Hindilerden I, Hindilerden F, Öner Doğan I, Beşışık F.
    Turk J Haematol. 2016 Apr 22. doi: 10.4274/tjh.2016.0083. [Epub ahead of print]

  • Serum Zinc Levels in Iron Deficiency in Women: A Case Control Study.
    Özhan O, Erdem N, Aydoğdu İ, Erkurt MA, Kuku İ.
    Turk J Haematol. 2016 Apr 18. doi: 10.4274/tjh.2015.0206. [Epub ahead of print]

  • Hepcidin: A Promising Therapeutic Target for Iron Disorders: A Systematic Review.
    Liu J, Sun B, Yin H, Liu S.
    Medicine (Baltimore). 2016 Apr;95(14):e3150. doi: 10.1097/MD.0000000000003150.

  • Iron Deficiency Anemia: Problems in Diagnosis and Prevention at the Population Level.
    Pasricha SR, Drakesmith H.
    Hematol Oncol Clin North Am. 2016 Apr;30(2):309-25. doi: 10.1016/j.hoc.2015.11.003.

  • Serum zinc levels in patients with iron deficiency anemia and its association with symptoms of iron deficiency anemia.
    Kelkitli E, Ozturk N, Aslan NA, Kilic-Baygutalp N, Bayraktutan Z, Kurt N, Bakan N, Bakan E.
    Ann Hematol. 2016 Apr;95(5):751-6. doi: 10.1007/s00277-016-2628-8. Epub 2016 Mar 2.

  • Response to parenteral iron therapy distinguish unexplained refractory iron deficiency anemia from iron-refractory iron deficiency anemia.
    Akin M, Sarbay H, Guler S, Balci YI, Polat A.
    Int J Lab Hematol. 2016 Apr;38(2):167-71. doi: 10.1111/ijlh.12462. Epub 2016 Jan 28.

  • Coexistence of Essential Thrombocythemia, Iron-Refractory Iron Deficiency Anemia and Renal Cell Carcinoma.
    Namdaroğlu S, Tekgündüz E, Altuntaş F.
    Hematol Rep. 2016 Mar 18;8(1):6235. doi: 10.4081/hr.2016.6235. eCollection 2016.

  • Introduction of new formulas and evaluation of the previous red blood cell indices and formulas in the differentiation between beta thalassemia trait and iron deficiency anemia in the Makkah region.
    Zaghloul A, Al-Bukhari TA, Bajuaifer N, Shalaby M, Al-Pakistani HA, Halawani SH, Teama SH, Wassif GA.
    Hematology. 2016 Mar 1:1-8. [Epub ahead of print]

  • Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study.
    Vadhan-Raj S, Ford DC, Dahl NV, Bernard K, Li Z, Allen LF, Strauss WE.
    Am J Hematol. 2016 Feb;91(2):E3-5. doi: 10.1002/ajh.24240.

  • Iron deficiency anemia treatment response to oral iron therapy: a pooled analysis of five randomized controlled trials.
    Okam MM, Koch TA, Tran MH.
    Haematologica. 2016 Jan;101(1):e6-7. doi: 10.3324/haematol.2015.129114. Epub 2015 Oct 30.

  • How we diagnose and treat iron deficiency anemia.
    Auerbach M, Adamson JW.
    Am J Hematol. 2016 Jan;91(1):31-8. doi: 10.1002/ajh.24201. Epub 2015 Nov 17.

  • Red Blood Cell Distribution Width and the Platelet Count in Iron-deficient Children Aged 0.5-3 Years
    Akkermans MD, Uijterschout L, Vloemans J, Teunisse PP, Hudig F, Bubbers S, Verbruggen S, Veldhorst M, de Leeuw TG, van Goudoever JB, Brus F.
    Pediatr Hematol Oncol. 2015 Nov 11:1-9.

  • Validation Study of the Composite Score to Identify Von Willebrand Disease in Children.
    Malec LM, Moore CG, Bennett CM, Yee DL, Kerlin BA, Witmer CM, Kulkarni R, Gupta S, Gunawardena S, Kouides PA, Brown D, Ragni MV.
    J Pediatr Hematol Oncol. 2015 Nov 3.

  • Mass spectrometry evaluation of the hepcidin-25 assay in thedifferential diagnosis of iron deficiency anaemia with concurrent inflammation and anaemia of inflammation in elderly patients.
    Karlsson T.
    Eur J Haematol. 2015 Nov;95(5):467-71. doi: 10.1111/ejh.12518. Epub 2015 Feb 10.

  • Discriminant indices for distinguishing thalassemia and iron deficiency in patients with microcytic anemia: a meta-analysis.
    Hoffmann JJ, Urrechaga E, Aguirre U.
    Clin Chem Lab Med. 2015 Nov 1;53(12):1883-94. doi:10.1515/cclm-2015-0179.

  • Hepcidin: a new biomarker of the iron deficiency anemia in elderly patients?
    Le Petitcorps H, Monti A, Pautas É.
    Ann Biol Clin (Paris). 2015 Nov 1;73(S1):24-25. PubMed PMID: 26620242.

  • Iron deficiency anemia treatment response to oral iron therapy: a pooled analysis of five randomized controlled trials.
    Okam MM, Koch TA, Tran MH.
    Haematologica. 2015 Oct 30. pii: haematol.2015.129114.

  • Reference intervals for reticulocyte parameters of infants during their first 90 days after birth.
    Christensen RD, Henry E, Bennett ST, Yaish HM.
    J Perinatol. 2015 Oct 29. doi: 10.1038/jp.2015.140. [Epub ahead of print] PubMed

  • Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).
    Lahoti A, Harris YT, Speiser PW, Atsidaftos E, Lipton JM, Vlachos A.
    Pediatr Blood Cancer. 2015 Oct 23. doi: 10.1002/pbc.25780. [Epub

  • Homeostasis of iron and hepcidin in erythropoietic protoporphyria.
    Bossi K, Lee J, Schmeltzer P, Holburton E, Groseclose G, Besur S, Hwang S, Bonkovsky HL.
    Eur J Clin Invest. 2015 Jul 21. doi: 10.1111/eci.12503.

  • Factors Associated with Hospitalization among Emergency Department Patients Referred for Quick Investigation of Iron-Deficiency Anemia.
    Bosch X, Monclús E, Inciarte A, Moreno P, Jordán A, López-Soto A.
    J Emerg Med. 2015 Oct 3. pii: S0736-4679(15)00900-2. doi: 10.1016/j.jemermed.2015.08.010. [Epub ahead of print]

  • Anemia of Central Origin.
    Ishii K, Young NS.
    Semin Hematol. 2015 Oct;52(4):321-38. doi: 10.1053/j.seminhematol.2015.07.002.

  • Anemia in Clinical Practice-Definition and Classification: Does Hemoglobin Change With Aging?
    Domenica Cappellini M, Motta I.
    Semin Hematol. 2015 Oct;52(4):261-9. doi: 10.1053/j.seminhematol.2015.07.006. Epub 2015 Jul 17.

  • Erythrocyte Catalase Activity in More Frequent Microcytic Hypochromic Anemia:Beta-Thalassemia Trait and Iron Deficiency Anemia.
    Lazarte SS, Mónaco ME, Jimenez CL, Ledesma Achem ME, Terán MM, Issé BA.
    Adv Hematol. 2015;2015:343571. doi: 10.1155/2015/343571.

  • Effect of iron deficiency anaemia on HbA1c levels is dependent on the degree of anaemia.
    Silva JF, Pimentel AL, Camargo JL.
    Clin Biochem. pii: S0009-9120(15)00434-8. doi: 10.1016/j.clinbiochem.2015.09.004

  • The Lack of Association of Iron Deficiency With Anemia in First Graders.
    Jaber L, Diamond G.
    J Pediatr Hematol Oncol. 2015 Oct;37(7):524-8. doi: 10.1097/MPH.0000000000000423.

  • Pernicious anemia: Normal ferritin levels and possible hidden iron deficiency.
    Fernández-Fernández FJ, Ameneiros-Lago E, Sesma P.
    Rev Clin Esp. 2015 Aug 19. pii: S0014-2565(15)00196-4. doi:10.1016/j.rce.2015.07.005.

  • Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management.
    Szebeni J, Fishbane S, Hedenus M, Howaldt S, Locatelli F, Patni S, Rampton D, Weiss G, Folkersen J.
    Br J Pharmacol. 2015 Aug 12. doi: 10.1111/bph.13268.

  • Reticulocyte parameters of delta beta thalassaemia trait, beta thalassaemia trait and iron deficiency anaemia.
    Velasco-Rodríguez D, Alonso-Domínguez JM, González-Fernández FA, Villarrubia J, Sopeña M, Abalo L, Ropero P, Martínez-Nieto J, de la Fuente Gonzalo F, Cava F.
    J Clin Pathol. 2015 Aug 11. pii: jclinpath-2015-203034. doi: 10.1136/jclinpath-2015-203034.

  • Outcomes Associated with Conventional Accelerated Versus Once-Weekly IV Iron Therapy in Outpatients Undergoing Hemodialysis.
    Malkinska M, El Nekidy WS, El-Masri MM, Kadri A, Donaldson C, Soong D.
    Can J Hosp Pharm. 2015 Jul-Aug;68(4):304-10.

  • Comparison of ferrous sulfate, polymaltose complex and iron-zinc in iron deficiency anemia.
    Ozsurekci Y, Unal S, Cetin M, Gumruk F.
    Minerva Pediatr. 2015 Jul 22.

  • Capillary electrophoresis method for speciation of iron (II) and iron (III) in pharmaceuticals by dual precapillary complexation.
    Gotti R, Fiori J, Liverani L, Spelta F.
    Electrophoresis. 2015 Jul 20. doi: 10.1002/elps.201500235.

  • An unusual case of iron deficiency anemia is associated with extremely low level of transferrin receptor.
    Hao S, Li H, Sun X, Li J, Li K.
    Int J Clin Exp Pathol. 2015 Jul 1;8(7):8613-8. eCollection 2015.

  • Six-day stability of erythrocyte and reticulocyte parameters in-vitro: A comparison of blood samples from healthy, iron-deficient, and thalassemic individuals.
    Sudmann-Day ÅA, Piehler A, Klingenberg O, Urdal P.
    Scand J Clin Lab Invest. 2015 May;75(3):247-53. doi: 10.3109/00365513.2014.1000370. Epub 2015 Jan 22.

  • Iron-induced thrombocytopenia in severe iron-deficiency anemia.
    Cunha V, Ferreira M, Barosa R, Fonseca AG, Delerue F, Carvalho C.
    Expert Rev Hematol. 2015 Apr;8(2):247-51. doi: 10.1586/17474086.2015.1010504.

  • Hepcidin: Regulation of the master iron regulator.
    Rishi G, Wallace DF, Subramaniam VN.
    Biosci Rep. 2015 Mar 31. [Epub ahead of print].

  • Evaluation of erythrocyte and reticulocyte parameters as indicative of iron deficiency in patients with anemia of chronic disease.
    Torino AB, Gilberti Mde F, da Costa E, de Lima GA, Grotto HZ.
    Rev Bras Hematol Hemoter. 2015 Mar-Apr;37(2):77-81. doi: 10.1016/j.bjhh.2015.02.004.

  • Increased expression of HIF2α during iron deficiency-associated megakaryocytic differentiation.
    Jimenez K, Khare V, Evstatiev R, Kulnigg-Dabsch S, Jambrich M, Strobl H, Gasche C.
    J Thromb Haemost. 2015 Feb 25. doi: 10.1111/jth.12884. [Epub ahead of print]

  • Association between venous thromboembolism and iron-deficiency anemia: a population-based study.
    Hung SH, Lin HC, Chung SD.
    Blood Coagul Fibrinolysis. 2015 Feb 13. [Epub ahead of print].

  • Management of iron deficiency anemia: A survey of pediatric hematology/oncology specialists.
    Powers JM, McCavit TL, Buchanan GR.
    Pediatr Blood Cancer. 2015 Feb 7. doi: 10.1002/pbc.25433. [Epub ahead of print].

  • Discrimination of various thalassemia syndromes and iron deficiency and utilization of reticulocyte measurements in monitoring response to iron therapy.
    Winichagoon P, Kumbunlue R, Sirankapracha P, Boonmongkol P, Fucharoen S.
    Blood Cells Mol Dis. 2015 Jan 20. pii: S1079-9796(15)00030-3. doi: 10.1016/j.bcmd.2015.01.010. [Epub ahead of print].

  • Intravenous ferric carboxymaltose-associated hypophosphatemia in patients with iron deficiency anemia. A common side effect.
    Sánchez González R, Ternavasio-de la Vega HG, Moralejo Alonso L, Inés Revuelta S, Fuertes Martín A.
    Med Clin (Barc). 2015 Jan 8. pii: S0025-7753(14)00808-2. doi: 10.1016/j.medcli.2014.10.016. [Epub ahead of print].

  • Effect of vitamin D replacement on hemoglobin concentration in subjects with concurrent iron-deficiency anemia and vitamin D deficiency: a randomized, single-blinded, placebo-controlled trial.
    Sooragonda B, Bhadada SK, Shah VN, Malhotra P, Ahluwalia J, Sachdeva N.
    Acta Haematol. 2015;133(1):31-5. doi: 10.1159/000357104. Epub 2014 Jul 8.

  • Mass spectrometry evaluation of the hepcidin-25 assay in the differential diagnosis of iron deficiency anaemia with concurrent inflammation and anaemia of inflammation in elderly patients.
    Karlsson T.
    Eur J Haematol. 2015 Jan 18. doi: 10.1111/ejh.12518. [Epub ahead of print].

  • The role of TMPRSS6 polymorphisms in iron deficiency anemia partially responsive to oral iron treatment.
    Poggiali E, Andreozzi F, Nava I, Consonni D, Graziadei G, Cappellini MD.
    Am J Hematol. 2014 Dec 31. doi: 10.1002/ajh.23929. [Epub ahead of print].

  • Ferric Carboxymaltose: A Review of Its Use in Iron Deficiency.
    Keating GM.
    Drugs. 2014 Nov 27. [Epub ahead of print]

  • Anti-carbonic anhydrase antibodies in iron deficiency anemia.
    Mentese A, Erkut N, SŸmer A, Altay DU, Alver A, Sönmez M.
    Hematology. 2014 Oct 6. [Epub ahead of print]

  • δβ-Thalassemia trait: how can we discriminate it from β-thalassemia trait and iron deficiency anemia?
    Velasco-Rodríguez D, Alonso-Domínguez JM, González-Fernández FA, Villarrubia J, Ropero P, Martínez-Nieto J, de la Fuente F, Guillén R, Acedo N, Serí C, Cava F.
    Am J Clin Pathol. 2014 Oct;142(4):567-73. doi: 10.1309/AJCPPBQ8UB1WHXTS.

  • Iron sucrose - characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas.
    Beguin Y, Jaspers A.
    Expert Opin Pharmacother. 2014 Oct;15(14):2087-103. doi: 10.1517/14656566.2014.953928. Epub 2014 Sep 4.

  • Encapsulation of Iron in Liposomes Significantly Improved the Efficiency of Iron Supplementation in Strenuously Exercised Rats.
    Xu Z, Liu S, Wang H, Gao G, Yu P, Chang Y.
    Biol Trace Elem Res. 2014 Oct 9. [Epub ahead of print]

  • Looking beyond the obvious: an unusual cause of iron deficiency anaemia.
    Jyotirmanju CS, Mallya P, Rau A, Rau AT.
    Indian J Hematol Blood Transfus. 2014 Sep;30(Suppl 1):183-5. doi: 10.1007/s12288-013-0321-9. Epub 2014 Jan 22.

  • Physicochemical and structural characterization of iron-sucrose formulations: a comparative study.
    Barot BS, Parejiya PB, Mehta DM, Shelat PK, Shah GB.
    Pharm Dev Technol. 2014 Aug;19(5):513-20. doi: 10.3109/10837450.2013.795171.

  • An analysis of the relationship between severe iron deficiency anemia and thrombocytopenia.
    Verma V, Ayalew G, Sidhu G, Ramnaraign B, Cutler J, Khandekar S, Weedon J, Sharma G, Braverman AS.
    Hematol Oncol Clin North Am. 2014 Aug;28(4):637-52, v. doi: 10.1016/j.hoc.2014.04.009. Epub 2014 May 28.

  • Iron-refractory iron deficiency anemia (IRIDA).
    Heeney MM, Finberg KE.
    Hematol Oncol Clin North Am.Ê2014 Aug;28(4):637-52, v. doi: 10.1016/j.hoc.2014.04.009. Epub 2014 May 28.

  • Diagnosis and management of iron deficiency anemia.
    Powers JM, Buchanan GR.
    Hematol Oncol Clin North Am. 2014 Aug;28(4):729-45, vi-vii. doi: 10.1016/j.hoc.2014.04.007. Epub 2014 Jun 2.

  • The Occurrence of Iron-Deficiency Anemia in Children With Type 1 Diabetes.
    Wójciak RW.
    J Invest Med, 2014; Jul 9.

  • Alterations of platelet functions in children and adolescents with iron-deficiency anemia and response to therapy.
    Mokhtar GM, Ibrahim WE, Kassim NA, Ragab IA, Saad AA, Abdel Raheem HG.
    Platelets. 2014 Jul 15:1-5. [Epub ahead of print]

  • Anemia in the elderly: clinical implications and new therapeutic concepts.
    Stauder R, Thein SL.
    Haematologica. 2014 Jul;99(7):1127-30. doi: 10.3324/haematol.2014.109967.

  • Molecular liaisons between erythropoiesis and iron metabolism.
    Kautz L, Nemeth E.
    Blood. 2014 Jul 24;124(4):479-82. doi: 10.1182/blood-2014-05-516252. Epub 2014 May 29.

  • Heme and erythropoieis: more than a structural role.
    Chiabrando D, et al.
    Haematologica, 2014 Jun; 99 (6): 973-983.

  • A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy.
    Hetzel D, et al.
    Am J Hematol, 2014 Jun; 89 (6): 646-650.

  • Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions.
    Cui R, Gale RP, Zhu G, Xu Z, Qin T, Zhang Y, Huang G, Li B, Fang L, Zhang H, Pan L, Hu N, Qu S, Xiao Z.
    Leuk Res. 2014 May;38(5):545-50. doi: 10.1016/j.leukres.2014.01.016. Epub 2014 Feb 10.

  • Transforming growth factor-β; superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis.
    Suragani RN, Cadena SM, Cawley SM, Sako D, Mitchell D, Li R, Davies MV, Alexander MJ, Devine M, Loveday KS, Underwood KW, Grinberg AV, Quisel JD, Chopra R, Pearsall RS, Seehra J, Kumar R.
    Nat Med. 2014 Apr;20(4):408-14. doi: 10.1038/nm.3512. Epub 2014 Mar 23.

  • Hematological indices for differential diagnosis of Beta thalassemia trait and iron deficiency anemia.
    Vehapoglu A, et al.
    Anemia, 2014; Apr.

  • Soluble transferrin receptor in complicated anemia.
    Braga F, et al.
    Clin Chim Acta, 2014; Apr; 431: 143-147.

  • Targeting a new regulator of erythropoiesis to alleviate anemia.
    Paulson RF.
    Nat Med. 2014 Apr; 20(4):334-5. doi: 10.1038/nm.3524.

  • Management of sickle cell disease in the community.
    Brousse V, Makani J, Rees DC.
    BMJ. 2014 Mar 10;348:g1765. doi: 10.1136/bmj.g1765.

  • A double red cells population in a woman with a microcytic anemia.
    Garçon L, Kannengiesser C.
    Blood. 2014 Feb 6;123(6):808.

  • Paroxysmal nocturnal hemoglobinuria diagnosed after influenza vaccine: coincidence or consequence?
    Green H, Eliakim-Raz N, Zimra Y, Gafter-Gvili A.
    Isr Med Assoc J. 2014 Feb;16(2):122-4.

  • Vitamin B12 and pernicious anemia--the dawn of molecular medicine.
    Bunn HF.
    N Engl J Med. 2014 Feb 20;370(8):773-6. doi: 10.1056/NEJMcibr1315544.

  • A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.
    Onken JE, Bregman DB, Harrington RA, Morris D, Acs P, Akright B, Barish C, Bhaskar BS, Smith-Nguyen GN, Butcher A, Koch TA, Goodnough LT.
    Transfusion. 2014 Feb;54(2):306-15. doi: 10.1111/trf.12289. Epub 2013 Jun 17.

  • Distribution of serum erythropoietin levels in lower risk myelodysplastic syndrome cases with anemia.
    Nakazaki K, Nannya Y, Kurokawa M.
    Int J Hematol. 2014 Jan;99(1):53-6. doi: 10.1007/s12185-013-1485-7.

  • Effects of iron therapy on blood lead concentrations in infants.
    Park S, Sim CS, Lee H, Kim Y.
    J Trace Elem Med Biol. 2014 Jan;28(1):56-9. doi: 10.1016/j.jtemb.2013.11.003.

  • Serum hepcidin following autologous hematopoietic cell transplantation : an illustration of the interplay of iron status, erythropoiesis and inflammation.
    Jaspers A, Baron F, Willems E, Seidel L, Wiegerinck ET, Swinkels DW, Beguin Y.
    Haematologica. 2014 Jan 17.

  • Efficiency of red cell distribution width in identification of children aged 1-3 years with iron deficiency anemia against traditional hematological markers.
    Sazawal S, Dhingra U, Dhingra P, Dutta A, Shabir H, Menon VP, Black RE.
    BMC Pediatr. 2014 Jan 15;14(1):8.

  • Iron requirements of infants and toddlers.
    Domellöf M, Braegger C, Campoy C, Colomb V, Decsi T, Fewtrell M, Hojsak I, Mihatsch W, Molgaard C, Shamir R, Turck D, van Goudoever J.
    J Pediatr Gastroenterol Nutr. 2014 Jan;58(1):119-29. doi: 10.1097/MPG.0000000000000206.

  • A multi-scale model of hepcidin promoter regulation reveals factors controlling systemic iron homeostasis.
    Casanovas G, Banerji A, d'Alessio F, Muckenthaler MU, Legewie S.
    PLoS Comput Biol. 2014 Jan;10(1):e1003421. doi: 10.1371/journal.pcbi.1003421.

  • Inappropriate expression of hepcidin by liver congestion contributes to anemia and relative iron deficiency.
    Suzuki T, Hanawa H, Jiao S, Ohno Y, Hayashi Y, Yoshida K, Kashimura T, Obata H, Minamino T.
    J Card Fail. 2014 Jan 15. pii: S1071-9164(14)00009-8. doi: 10.1016/j.cardfail.2014.01.008.

  • The liver: conductor of systemic iron balance.
    Meynard D, Babitt JL, Lin HY.
    Blood. 2014 Jan 9;123(2):168-76. doi: 10.1182/blood-2013-06-427757.

  • Black soyabean seed coat extract regulates iron metabolism by inhibiting the expression of hepcidin.
    Mu M, Wu A, An P, Du X, Wu Q, Shen X, Wang F.
    Br J Nutr. 2014 Jan 6:1-9.

  • A nano-disperse ferritin-core mimetic that efficiently corrects anaemia without luminal iron redox activity.
    Powell JJ, Bruggraber SF, Faria N, Poots LK, Hondow N, Pennycook TJ, Latunde-Dada GO, Simpson RJ, Brown AP, Pereira DI.
    Nanomedicine. 2014 Jan 3. pii: S1549-9634(13)00776-4. doi: 10.1016/j.nano.2013.12.011.

  • How I treat unexplained refractory iron deficiency anemia.
    Hershko C, Camaschella C.
    Blood. 2014 Jan 16;123(3):326-33. doi: 10.1182/blood-2013-10-512624.

  • Oral manifestations and blood profile in patients with iron deficiency anemia.
    Wu YC, Wang YP, Chang JY, Cheng SJ, Chen HM, Sun A.
    J Formos Med Assoc. 2013 Dec 30. pii: S0929-6646(13)00406-3. doi: 10.1016/j.jfma.2013.11.010.

  • Use of non-invasive total hemoglobin measurement as a screening tool for anemia in children.
    Amano I, Murakami A.
    Pediatr Int. 2013 Dec;55(6):803-5. doi: 10.1111/ped.12236.

  • A systematic analysis of global anemia burden from 1990 to 2010.
    Kassebaum NJ, Jasrasaria R, Naghavi M, Wulf SK, Johns N, Lozano R, Regan M, Weatherall D, Chou DP, Eisele TP, Flaxman SR, Pullan RL, Brooker SJ, Murray CJ.
    Blood. 2013 Dec 2.

  • Hematologic manifestations of systemic disease (including iron deficiency, anemia of inflammation and DIC).
    Witmer CM.
    Pediatr Clin North Am.2013 Dec;60(6):1337-48. doi: 10.1016/j.pcl.2013.08.012.

  • Anemias.
    Broadway-Duren JB, Klaassen H.
    Crit Care Nurs Clin North Am.2013 Dec;25(4):411-26, v. doi: 10.1016/j.ccell.2013.09.004.

  • Is a 40 % absorption of iron from a ferrous ascorbate reference dose appropriate to assess iron absorption independent of iron status?
    Valenzuela C, Olivares M, Brito A, Hamilton-West C, Pizarro F.
    Biol Trace Elem Res.2013 Dec;155(3):322-6. doi: 10.1007/s12011-013-9797-2.

  • Influence of several sources and amounts of iron on DNA, lipid and protein oxidative damage during anaemia recovery.
    Díaz-Castro J, García Y, López-Aliaga I, Alférez MJ, Hijano S, Ramos A, Campos MS.
    Biol Trace Elem Res. 2013 Dec;155(3):403-10. doi: 10.1007/s12011-013-9802-9.

  • Unexplained chronic leukopenia treated with oral iron supplements.
    Abuirmeileh A, Bahnassi A, Abuirmeileh A.
    Int J Clin Pharm.2013 Dec 18.

  • A forgotten screening test for iron deficiency anemia: Oral iron absorption test.
    Hacibekiroglu T, Akinci S, Basturk AR, Bakanay SM, Ulas T, Guney T, Dilek I.
    Clin Ter. 2013 Nov-Dec;164(6):495-7. doi: 10.7417/CT.2013.1627.

  • Low hemoglobin deferral in blood donors.
    Mast AE.
    Transfus Med Rev.2013 Nov 12. pii: S0887-7963(13)00086-2. doi: 10.1016/j.tmrv.2013.11.001.

  • Functional significance of early-life iron deficiency: outcomes at 25 years.
    Lozoff B, Smith JB, Kaciroti N, Clark KM, Guevara S, Jimenez E.
    J Pediatr.2013 Nov;163(5):1260-6. doi: 10.1016/j.jpeds.2013.05.015.

  • Iron status in the elderly.
    Fairweather-Tait SJ, Wawer AA, Gillings R, Jennings A, Myint PK.
    Mech Ageing Dev.2013 Nov 22. pii: S0047-6374(13)00124-3. doi: 10.1016/j.mad.2013.11.005.

  • Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron.
    Plummer ES, Crary SE, McCavit TL, Buchanan GR.
    Pediatr Blood Cancer.2013 Nov;60(11):1747-52. doi: 10.1002/pbc.24676.

  • Iron deficiency anemia as a risk factor for cerebrovascular events in early childhood: a case-control study.
    Azab SF, Abdelsalam SM, Saleh SH, Elbehedy RM, Lotfy SM, Esh AM, Srea MA, Aziz KA.
    Ann Hematol.2013 Oct 19. [Epub ahead of print]

  • Responsiveness to Parenteral Iron Therapy in Children with Oral Iron-Refractory Iron-Deficiency Anemia.
    Akin M, Atay E, Oztekin O, Karadeniz C, Karakus YT, Yilmaz B, Erdogan F.
    Pediatr Hematol Oncol.2013 Oct 2. [Epub ahead of print]

  • Iron deficiency: from diagnosis to treatment.
    Polin V, Coriat R, Perkins G, Dhooge M, Abitbol V, Leblanc S, Prat F, Chaussade S.
    Dig Liver Dis.2013 Oct;45(10):803-9. doi: 10.1016/j.dld.2013.02.019.

  • Budget impact of parenteral iron treatment ofiron deficiency: methodological issues raised by using real-life data.
    Brock E, Braunhofer P, Troxler J, Schneider H.
    Eur J Health Econ.2013 Oct 1.

  • Effects of omeprazole on iron absorption: preliminary study.
    Tempel M, Chawla A, Messina C, Celiker MY.
    Turk J Haematol. 2013 Sep;30(3):307-10. doi: 10.5152/tjh.2013.0042.

  • Iron deficiency anemia in low- and middle-income countries.
    Ruiz-Argüelles GJ.
    Blood.2013 Sep 26;122(13):2289. doi: 10.1182/blood-2013-05-505297.

  • Intravenous irontherapy for treatment of anaemia.
    McIntyre LA, Tinmouth A, Fergusson D.
    BMJ.2013 Sep 3;347:f5378. doi: 10.1136/bmj.f5378.

  • Effect of iron liposomes on anemia of inflammation.
    Yuan L, Geng L, Ge L, Yu P, Duan X, Chen J, Chang Y.
    Int J Pharm.2013 Sep 15;454(1):82-9. doi: 10.1016/j.ijpharm.2013.06.078.

  • Iron deficiency anemia in late-preterm infants.
    Ozdemir H, Akman I, Demirel U, Co?kun S, Bilgen H, Ozek E.
    Turk J Pediatr. 2013 Sep-Oct;55(5):500-5.

  • Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron.
    Vadhan-Raj S, Strauss W, Ford D, Bernard K, Boccia R, Li J, Allen LF.
    Am J Hematol.2013 Aug 26. doi: 10.1002/ajh.23582. [Epub ahead of print]

  • Anemia of chronic disease.
    Gangat N, Wolanskyj AP.
    Semin Hematol.2013 Jul;50(3):232-8. doi: 10.1053/j.seminhematol.2013.06.006.

  • Iron deficiency anemia: a common and curable disease.
    Miller JL.
    Cold Spring Harb Perspect Med.2013 Jul 1;3(7). pii: a011866. doi: 10.1101/cshperspect.a011866.

  • Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia.
    Hussain I, Bhoyroo J, Butcher A, Koch TA, He A, Bregman DB.
    Anemia.2013;2013:169107. doi: 10.1155/2013/169107.

  • Hepcidin as a central mediator of anemia of chronic diseases associated with obesity.
    Villarroel HP, Arredondo OM, Olivares GM.
    Rev Med Chil. 2013 Jul;141(7):887-94. doi: 10.4067/S0034-98872013000700008.

  • Congenital diaphragmatic hernia and iron deficiency anemia.
    Ozsoylu S.
    Turk J Haematol. 2013 Jun;30(2):225. doi: 10.4274/Tjh.2013.0059.

  • Screening bleeding disorders in adolescents and young women with menorrhagia.
    Cak? K?l?ç S, Sarper N, Zengin E, Aylan Gelen S.
    Turk J Haematol. 2013 Jun;30(2):168-76. doi: 10.4274/Tjh.2011.0048.

  • Iron (III) isomaltoside 1000.
    Mace TA, Syed A, Bhandari S.
    Expert Rev Hematol.2013 Jun;6(3):239-46. doi: 10.1586/ehm.13.15.

  • Iron refractory iron deficiency anemia.
    De Falco L, Sanchez M, Silvestri L, Kannengiesser C, Muckenthaler MU, Iolascon A, Gouya L, Camaschella C, Beaumont C.
    Haematologica.2013 Jun;98(6):845-53. doi: 10.3324/haematol.2012.075515.

  • Effects of Zinc Sulfate Supplementation in Treatment of Iron Defi ciency Anemia.
    Gülsan M, Malbora B, Avc? Z, Bayraktar N, Bozkaya I, Ozbek N.
    Turk J Haematol. 2013 Jun;30(2):144-52. doi: 10.4274/Tjh.2012.0043.

  • Low hemoglobin density as a measure of iron status.
    Damodar S, Raghunath ST, Murthy S, Jayanthi KJ, S Latha BR.
    Indian J Hematol Blood Transfus. 2013 Jun;29(2):75-6. doi: 10.1007/s12288-012-0162-y.

  • A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.
    Onken JE, Bregman DB, Harrington RA, Morris D, Acs P, Akright B, Barish C, Bhaskar BS, Smith-Nguyen GN, Butcher A, Koch TA, Goodnough LT.
    Transfusion.2013 Jun 17. doi: 10.1111/trf.12289.

  • Differences in circulating non-transferrin-bound iron after oral administration of ferrous sulfate, sodium iron EDTA, or iron polymaltose in women with marginal iron stores.
    Schümann K, Solomons NW, Orozco M, Romero-Abal ME, Weiss G.
    Food Nutr Bull.2013 Jun;34(2):185-93.

  • Effect of iron intervention on growth during gestation, infancy, childhood, and adolescence: a systematic review with meta-analysis.
    Vucic V, Berti C, Vollhardt C, Fekete K, Cetin I, Koletzko B, Gurinovic M, van't Veer P.
    Nutr Rev.2013 Jun;71(6):386-401. doi: 10.1111/nure.12037.

  • Iron deficiency anemia and levels of oxidative stress induced by treatment modality.
    Akarsu S, Demir H, Selek S, Oguzoncul F.
    Pediatr Int.2013 Jun;55(3):289-95. doi: 10.1111/ped.12054.

  • Iron deficiency: what are the future trends in diagnostics and therapeutics?
    Brugnara C, Adamson J, Auerbach M, Kane R, Macdougall I, Mast A.
    Clin Chem.2013 May;59(5):740-5. doi: 10.1373/clinchem.2012.182071.

  • Treatment of iron deficiency anemia in children: a comparative study of ferrous ascorbate and colloidal iron.
    Yewale VN, Dewan B.
    Indian J Pediatr.2013 May;80(5):385-90. doi: 10.1007/s12098-012-0906-6.

  • The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia.
    Allen RP, Auerbach S, Bahrain H, Auerbach M, Earley CJ.
    Am J Hematol.2013 Apr;88(4):261-4. doi: 10.1002/ajh.23397.

  • Tolerability of different oral iron supplements: a systematic review.
    Cancelo-Hidalgo MJ, Castelo-Branco C, Palacios S, Haya-Palazuelos J, Ciria-Recasens M, Manasanch J, Pérez-Edo L.
    Curr Med Res Opin.2013 Apr;29(4):291-303. doi: 10.1185/03007995.2012.761599.

  • Effects of daily iron supplementation in 2- to 5-year-old children: systematic review and meta-analysis.
    Thompson J, Biggs BA, Pasricha SR.
    Pediatrics.2013 Apr;131(4):739-53. doi: 10.1542/peds.2012-2256.

  • Attendance at iron deficiency anaemia clinic: audit of outcomes 5 years on.
    Pengelly S, Fabricius M, McMenamin D, Wu E, Metzner M, Lewis SJ, Hosie KB.
    Colorectal Dis.2013 Apr;15(4):423-7. doi: 10.1111/codi.12040.

  • Iron deficiency anemia in infants: does it really affect the myocardial functions?
    Alioglu B, Cetin II, Emeksiz ZS, Dindar N, Tapci E, Dallar Y.
    Pediatr Hematol Oncol.2013 Apr;30(3):239-45. doi: 10.3109/08880018.2012.763077.

  • Relationship between blood donors' iron status and their age, body mass index and donation frequency.
    Moghadam AM, Natanzi MM, Djalali M, Saedisomeolia A, Javanbakht MH, Saboor-Yaraghi AA, Zareei M.
    Sao Paulo Med J.2013;131(6):377-83. doi: 10.1590/1516-3180.2013.1316554.

  • Diagnosis of iron deficiency anemia in the elderly: when to say "uncle".
    Kozarek R.
    Dig Dis Sci.2013 Feb;58(2):287-8. doi: 10.1007/s10620-012-2452-5.

  • Iron refractory iron deficiency anemia: presentation with hyperferritinemia and response to oral iron therapy.
    Khuong-Quang DA, Schwartzentruber J, Westerman M, Lepage P, Finberg KE, Majewski J, Jabado N.
    Pediatrics.2013 Feb;131(2):e620-5. doi: 10.1542/peds.2012-1303.

  • Iron deficiency anemia: evaluation and management.
    Short MW, Domagalski JE.
    Am Fam Physician.2013 Jan 15;87(2):98-104.

  • Treatment of anemia in the adolescent female.
    Grooms LP, Walsh M, Monnat LE.
    Pediatr Ann.2013 Jan;42(1):36-9. doi: 10.3928/00904481-20121221-17.

  • Pathogenesis and clinical implications of HIV-related anemia in 2013.
    Redig AJ, Berliner N.
    Hematology Am Soc Hematol Educ Program. 2013;2013:377-81. doi: 10.1182/asheducation-2013.1.377.

  • Iron and hepcidin: a story of recycling and balance.
    Camaschella C.
    Hematology Am Soc Hematol Educ Program. 2013;2013:1-8. doi: 10.1182/asheducation-2013.1.1.

Deje su comentario:
Entre en su área de usuario para comentar.
No hay comentarios.